Perspective Therapeutics (CATX) EPS (Weighted Average and Diluted) (2023 - 2026)
Perspective Therapeutics recorded quarterly EPS (Weighted Average and Diluted) of -$0.25 in Q1 2026, up 50.98% quarter-over-quarter from -$0.51 in Q4 2025, and little changed year-over-year from -$0.25 in Q1 2025.
Perspective Therapeutics' EPS (Weighted Average and Diluted) history runs 4 years deep, the most recent figure standing at -$0.25 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) changed 0.0% year-over-year to -$0.25; the TTM figure through Mar 2026 stood at -$1.41 (down 13.71% YoY), while the FY2025 annual figure was -$1.41, down 15.57% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.25 for Q1 2026 at Perspective Therapeutics, up from -$0.51 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.01 in Q1 2023 to a low of -$1.06 in Q4 2023.
- A 4-year average of -$0.36 and a median of -$0.3 in 2025 frame the typical range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 47.06% in 2024 and fell as far as 2600.0% in 2024.
- Perspective Therapeutics' EPS (Weighted Average and Diluted) stood at -$1.06 in 2023, then jumped by 43.4% to -$0.6 in 2024, then increased by 15.0% to -$0.51 in 2025, then surged by 50.98% to -$0.25 in 2026.
- According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.25, -$0.51, and -$0.35 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.25 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.35 |
| Jun 30, 2025 | -0.30 |
| Mar 31, 2025 | -0.25 |
| Dec 31, 2024 | -0.60 |
| Sep 30, 2024 | -0.21 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -1.06 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.34 |
| Mar 31, 2023 | 0.01 |